Chylomicron retention disease

Chylomicron retention disease is a disorder of fat absorption.[2] It is associated with SAR1B.[3] Mutations in SAR1B prevent the release of chylomicrons in the circulation which leads to nutritional and developmental problems.[4] It is a rare autosomal recessive disorder with around 40 cases reported worldwide. Since the disease allele is recessive, parents usually do not show symptoms.[4]

Chylomicron retention disease
Other namesAnderson disease [1]
This condition is inherited in an autosomal recessive manner

Without functional chylomicrons certain fat-soluble vitamins such as vitamin D and vitamin E cannot be absorbed. Chylomicrons have a crucial role in fat absorption and transport, thus deficiency in chylomicron functioning reduces available levels of dietary fats and fat-soluble vitamins.[4]

Signs and symptoms

In the months following birth, signs and symptoms will appear. Some symptoms will manifest gradually during childhood.[4]

Diagnosis

Treatment

References

  1. RESERVED, INSERM US14-- ALL RIGHTS. "Orphanet: Chylomicron retention disease". www.orpha.net. Retrieved 17 July 2019.
  2. Roy CC, Levy E, Green PH, et al. (February 1987). "Malabsorption, hypocholesterolemia, and fat-filled enterocytes with increased intestinal apoprotein B. Chylomicron retention disease". Gastroenterology. 92 (2): 390–9. PMID 3792776.
  3. Jones B, Jones EL, Bonney SA, et al. (May 2003). "Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders". Nat. Genet. 34 (1): 29–31. doi:10.1038/ng1145. PMID 12692552.
  4. http://ghr.nlm.nih.gov/condition/chylomicron-retention-disease
Classification
External resources
  • Orphanet: 71


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.